bpc-157 peptid BPC-157: What It Is, What We Know, and Why Its Use for Arthritis Remains Unproven FDA panel backs compounded BPC-157,

This approval represents the first FDA-approved drug specifically targeting mitochondrial function, establishing regulatory precedent for the mitochondrial dysfunction pathway in aging and neurodegeneration

These effects are often studied through molecular markers rather than behavioral outcomes, reinforcing the strictly mechanistic nature of this research

Furthermore, HIF-1 and HO-1 protein levels were markedly increased in the model group compared with the control, and DHA treatment partially reversed these changes (Fig

It supports tissue regeneration, gut protection, and vascular healing, making it one of the most versatile compounds in modern peptide therapy